ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Dingell Subcommittee Report Next Month To Include New Info

July 1, 1994

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

Changes In Cooperative Groups As Result Of Move To DCT Topic Of Chairmen’s Meeting Sept. 16

August 22, 1975

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004

Sept. Is AMA’s Month of Women In Medicine

September 10, 1993